Cheng-lung is a co-founder and scientific advisor of Elixiron Immunotherapeutics, along with sitting on the board of directors. He currently serves as Associate Professor of Graduate Institute of Clinical Medical Sciences at Chang Gung University, Taiwan. Cheng-Lung’s major research interests are studying human immunological disorders and infectious diseases, particularly pathological roles of anti-cytokine autoantibodies (Blood 2013) and developmental therapeutics for the diseases (Nature Medicine 2016). His laboratory has established state-of-the-art technology platforms for immunological profiling in patients and generation of human derived monoclonal antibodies. Cheng-Lung has published extensively and has won numerous awards and honors for his research. He received his Ph.D. in Immunology from Université Paris Descartes, Paris.